Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
NDC API
0
VMF
0
EDQM
0
USP
0
JP
0
Others
0
FDA Orange Book
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. 2,5 Dihydroxybenzenesulfonate
2. 2,5 Dihydroxybenzenesulfonic Acid
3. 2,5-dihydroxybenzenesulfonate
4. 2,5-dihydroxybenzenesulfonic Acid
5. Calcium Dobesilate (1:1)
6. Calcium Dobesilate Monoammonium Salt
7. Calcium Dobesilate Monopotassium Salt
8. Calcium, Dobesilate
9. Dexium
10. Dobesilate Calcium
11. Dobesilate, Calcium
12. Dobica
13. Doxium
1. 20123-80-2
2. Dexium
3. Dobesilate Calcium
4. Doxium
5. Calcium 2,5-dihydroxybenzenesulfonate
6. Hydroquinone Calcium Sulfonate
7. Calcium Dobesilate [inn]
8. 205 E
9. Benzenesulfonic Acid, 2,5-dihydroxy-, Calcium Salt (2:1)
10. 2,5-dihydroxybenzenesulfonic Acid Calcium Salt
11. Calcium Doxybensylate
12. Calcii Dobesilas
13. 205-e
14. 5921x1560q
15. Calcium Dobesilate (inn)
16. Dobesilato Calcico
17. Doxi-om
18. Dobesilate De Calcium
19. Calcium Bis(2,5-dihydroxybenzenesulfonate)
20. Calcium Dobesilate Hydrate
21. Calciumdobesilate
22. Calcium Hydrochinonsulfonat
23. Dobesilato Calcio
24. Dobesilato Di Calcio [dcit]
25. Dobesilato Di Calcio
26. Calcii Dobesilas [inn-latin]
27. Dobesilato Calcio [inn-spanish]
28. Dobesilate De Calcium [inn-french]
29. Einecs 243-531-5
30. Calcium Bis(2,5-dihydroxybenzolsulfonat)
31. Unii-5921x1560q
32. Doxium (tn)
33. Calcium Dobesilate,(s)
34. Schembl148396
35. Benzenesulfonic Acid, 2,5-dihydroxy-, Calcium Salt
36. 2,5-dihydroxybenzenesulfonic Acid Calcium Salt (2:1)
37. Dobesilate Calcium [mi]
38. Chembl2106191
39. Exo-2-aminonorbornane99
40. Dtxsid60173946
41. Bcp13786
42. Calcium Dobesilate [who-dd]
43. Akos005267175
44. Dobesilate Calcium, >=98% (hplc)
45. Calcium 2,5-bis(oxidanyl)benzenesulfonate
46. Db-045100
47. Hy-111603
48. Cs-0088365
49. Ft-0625554
50. Calcium 2,5-dihydroxybenzenesulphonate
51. D07427
52. D70205
53. A814261
54. J-013032
55. Q5018825
| Molecular Weight | 418.4 g/mol |
|---|---|
| Molecular Formula | C12H10CaO10S2 |
| Hydrogen Bond Donor Count | 4 |
| Hydrogen Bond Acceptor Count | 10 |
| Rotatable Bond Count | 0 |
| Exact Mass | 417.9341297 g/mol |
| Monoisotopic Mass | 417.9341297 g/mol |
| Topological Polar Surface Area | 212 Ų |
| Heavy Atom Count | 25 |
| Formal Charge | 0 |
| Complexity | 228 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 3 |
Hemostatics
Agents acting to arrest the flow of blood. Absorbable hemostatics arrest bleeding either by the formation of an artificial clot or by providing a mechanical matrix that facilitates clotting when applied directly to the bleeding surface. These agents function more at the capillary level and are not effective at stemming arterial or venous bleeding under any significant intravascular pressure. (See all compounds classified as Hemostatics.)
C - Cardiovascular system
C05 - Vasoprotectives
C05B - Antivaricose therapy
C05BX - Other sclerosing agents
C05BX01 - Calcium dobesilate
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us 
FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Global Sales Information
Market Place
ABOUT THIS PAGE
74
PharmaCompass offers a list of Calcium Dobesilate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Calcium Dobesilate manufacturer or Calcium Dobesilate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Calcium Dobesilate manufacturer or Calcium Dobesilate supplier.
PharmaCompass also assists you with knowing the Calcium Dobesilate API Price utilized in the formulation of products. Calcium Dobesilate API Price is not always fixed or binding as the Calcium Dobesilate Price is obtained through a variety of data sources. The Calcium Dobesilate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Calcium Dobesilate [INN] manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Calcium Dobesilate [INN], including repackagers and relabelers. The FDA regulates Calcium Dobesilate [INN] manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Calcium Dobesilate [INN] API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Calcium Dobesilate [INN] manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Calcium Dobesilate [INN] supplier is an individual or a company that provides Calcium Dobesilate [INN] active pharmaceutical ingredient (API) or Calcium Dobesilate [INN] finished formulations upon request. The Calcium Dobesilate [INN] suppliers may include Calcium Dobesilate [INN] API manufacturers, exporters, distributors and traders.
click here to find a list of Calcium Dobesilate [INN] suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Calcium Dobesilate [INN] Drug Master File in Korea (Calcium Dobesilate [INN] KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Calcium Dobesilate [INN]. The MFDS reviews the Calcium Dobesilate [INN] KDMF as part of the drug registration process and uses the information provided in the Calcium Dobesilate [INN] KDMF to evaluate the safety and efficacy of the drug.
After submitting a Calcium Dobesilate [INN] KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Calcium Dobesilate [INN] API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Calcium Dobesilate [INN] suppliers with KDMF on PharmaCompass.
A Calcium Dobesilate [INN] written confirmation (Calcium Dobesilate [INN] WC) is an official document issued by a regulatory agency to a Calcium Dobesilate [INN] manufacturer, verifying that the manufacturing facility of a Calcium Dobesilate [INN] active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Calcium Dobesilate [INN] APIs or Calcium Dobesilate [INN] finished pharmaceutical products to another nation, regulatory agencies frequently require a Calcium Dobesilate [INN] WC (written confirmation) as part of the regulatory process.
click here to find a list of Calcium Dobesilate [INN] suppliers with Written Confirmation (WC) on PharmaCompass.
Calcium Dobesilate [INN] Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Calcium Dobesilate [INN] GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Calcium Dobesilate [INN] GMP manufacturer or Calcium Dobesilate [INN] GMP API supplier for your needs.
A Calcium Dobesilate [INN] CoA (Certificate of Analysis) is a formal document that attests to Calcium Dobesilate [INN]'s compliance with Calcium Dobesilate [INN] specifications and serves as a tool for batch-level quality control.
Calcium Dobesilate [INN] CoA mostly includes findings from lab analyses of a specific batch. For each Calcium Dobesilate [INN] CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Calcium Dobesilate [INN] may be tested according to a variety of international standards, such as European Pharmacopoeia (Calcium Dobesilate [INN] EP), Calcium Dobesilate [INN] JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Calcium Dobesilate [INN] USP).
